Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
aldehyde
aldeyra therapeutics
allergic conjunctivitis
azacitidine
beta-thalassemia
biotech
clinical trials
dacogen
deals
decitabine
dna
drugs
dry eye disease
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
insulated genomic domains
kaleido biosciences
mahesh karande
national top stories
new york blog main
new york top stories
omega therapeutics
panobinostat
reproxalab
richard young
robert gould
rudolf jaenisch
san francisco blog main
san francisco top stories
sickle cell disease
sjogren-larsson syndrome
startups
What
new
step
2
×
therapeutics
2
×
aims
aldeyra
approach
based
biotech
called
closer
data
debuts
developing
disclosed
drug
drugs
epigenetic
epigenetics
eye
fda
field
fighting
filing
flagship’s
inflammation
medicine
medicines
morning
multiple
omega
phase
positive
puts
research
results
startup
studies
touting
type
Language
unset
Current search:
step
×
boston
×
therapeutics
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
